G. Michael Bright

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

Ronald P. Gladue, G. Michael Bright, Richard E. Isaacson et al. · Antimicrobial Agents and Chemotherapy · 1989 · 476 citations

Medicine, Immunology, Pharmacology +14

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

James A. Retsema, Agnès Girard, W Schelkly et al. · Antimicrobial Agents and Chemotherapy · 1987 · 461 citations

Medicine, Infectious Diseases, Medicinal Chemistry +11

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.

G. Michael Bright, A. Nagel, Jon Bordner et al. · The Journal of Antibiotics · 1988 · 238 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Perturbed [12]annulenes. Synthesis of pyracylenes

Barry M. Trost, G. Michael Bright, Charles R. Frihart et al. · Journal of the American Chemical Society · 1971 · 91 citations

Natural Sciences, Chemistry, Analytical Chemistry +6

Pyracylene. Pentalenoid system

Barry M. Trost, G. Michael Bright · Journal of the American Chemical Society · 1967 · 52 citations

Natural Sciences, Chemistry, Analytical Chemistry +5